Effects of Omalizumab Treatment on Some Biomarkers in Severe Allergic Asthma Patients

ONUR S. T., Yalcin A. D., GÜMÜŞLÜ S., Genc G. E., Kiraz K., ALTIN S.

EURASIAN JOURNAL OF PULMONOLOGY, cilt.19, sa.2, ss.84-90, 2017 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5152/ejp.2017.64935
  • Dergi Adı: EURASIAN JOURNAL OF PULMONOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.84-90
  • Anahtar Kelimeler: Asthma, biomarkers, omalizumab, ANTI-IGE, CYTOKINE PRODUCTION, HOMOCYSTEINE, EOSINOPHIL, IL-1-BETA, SCD200, CELLS
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objective: The mechanism of biological treatment molecule called omalizumab used in asthma treatment is thought to be versatile; however, the mechanism still remains unknown. This study was undertaken in severe asthma patients underwent omalizumab treatment, in order to investigate the relationship between biomarker expression and disease characteristics related to the immune system.